Related references
Note: Only part of the references are listed.Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI
C. C. Quarles et al.
MAGNETIC RESONANCE IN MEDICINE (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D
BA Moffat et al.
CLINICAL CANCER RESEARCH (2006)
Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters
CC Quarles et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2005)
Quantitative models of the rat pulmonary arterial tree morphometry applied to hypoxia-induced arterial remodeling
RC Molthen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps
MA Badruddoja et al.
NEURO-ONCOLOGY (2003)
MR-derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis
AP Pathak et al.
MAGNETIC RESONANCE IN MEDICINE (2001)
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy
EB Brown et al.
NATURE MEDICINE (2001)
Openings between defective endothelial cells explain tumor vessel leakiness
H Hashizume et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
